Loading…
← CockpitCompetitor Analysis › DRW8.DE Draegerwerk AG & Co. KGaAOpen in the cockpit ↗

Draegerwerk AG & Co. KGaADRW8.DECompetitor analysis, valuation and peers

Germany · EUR·Health Care›Medical Specialties

German maker of medical ventilators, anesthesia machines and patient monitors, plus safety equipment like gas detectors and respiratory protection.

≈ A German GE Healthcare (respiratory) combined with an MSA SafetyMomentum leader 96
Mkt cap
$2.13B
US dollars, full cap
Free float
28%
of shares outstanding
$/day
$375,100
20-day average traded
Fwd P/E
10.2×
forward earnings
ROIC−WACC
+5.1 pp
WACC 6.1%
Hurdle
-11 pp
Req g minus delivered
Next earnings
119 days
17 Mar 2027
Close · EUR€89.40
1D+7.5%
1W+8.2%
1M+28.1%
3M+8.8%
6M+24.9%
YTD+58.5%
1Y+43.7%
ATR %3.8%
52w lowhigh6.9% off high

What Draegerwerk AG & Co. KGaA does

German maker of medical ventilators, anesthesia machines and patient monitors, plus safety equipment like gas detectors and respiratory protection.

Two arms: medical devices for operating theatres and intensive care, and safety equipment for fire services, mines and industry. A sale is followed by years of service contracts, accessories and consumables, so the installed base is a steady income source. The Draeger family controls it through voting shares; this preferred share has no vote.

In one line: A German GE Healthcare (respiratory) combined with an MSA Safety.

Products and services

  • Ventilators/anesthesia machines
  • Patient monitoring systems
  • Gas detection equipment
  • Respiratory protection (firefighting/industrial masks)

Customers

  • Hospitals/ICUs
  • Firefighters/first responders
  • Industrial safety customers (oil & gas, mining)

Where it sits in the supply chain

  • Health Care/Industrials
  • Medical devices & safety equipment
  • Respiratory medical devices…

What could go right

  • Hospital ICU capacity investment
  • Industrial safety regulation compliance demand

What could go wrong

  • Post-pandemic ventilator demand normalization
  • Hospital capex budget constraints

Moat: narrow (brand, regulatory licence, installed base). Trusted safety-critical medical and safety-equipment brand with regulatory approvals, but competes with larger med-tech/safety players.

Headquarters: Luebeck, Germany · Founded: 1889 · Employees: 16,687

Named competitors

Draegerwerk AG & Co. KGaA at a glance

Size Draegerwerk AG & Co. KGaA (DRW8.DE) is a Germany Health Care company (Medical Specialties) with a market value of $2.13B, the 103rd largest of 198 Germany companies the cockpit tracks. Shares closed at €89.40 on 18 Nov 2026.

Performance Over six months the shares gained 24.9%, against +1.1% for the median peer and -0.9% for the Germany market (cap-weighted) — 4th highest of 20 in its peer set.

Growth Revenue grew 5.1% over the last twelve months (peer median +7.9%); the operating margin is 7.4% (peer median 15.2%).

Valuation It trades at 10.2× forward earnings against a peer median of 24.1× (2nd cheapest of 19).

Price implies For today's price to make sense, revenue must grow about -10% a year for seven years (Req g). Recent delivered growth is 0%, so the hurdle is -11 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 5.1 points above its cost of capital (6.1% WACC).

Next results Next results expected around 17 Mar 2027 (exchange calendar; dates can move).

Relative performance

10012021 May 202621 Aug 202618 Nov 2026DRW8.DE 122Peer median 101
Six months, rebased to 100: Draegerwerk AG & Co. KGaA against the median of its 20 peers (local-currency closes).

Draegerwerk AG & Co. KGaA financials

Reported figures in EUR; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€3.59B€3.48B€3.37B€3.37B€3.05B
Revenue growth—+3%0%+11%—
Gross profit€1.67B€1.52B€1.43B€1.40B€1.17B
EBITDA€405M€385M€313M€341M€72.9M
Net income€170M€139M€124M€110M-€64.6M
Free cash flow€227M€167M€107M€125M-€224M
Capital expenditure€105M€80.7M€63.8M€68.2M€86.9M
Total debt€229M€405M€396M€471M€362M

Quarterly statements and history in the cockpit →

Draegerwerk AG & Co. KGaA competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-25%0%+25%6951ESTAMETNVCYTBONEX2276688029EKTA-B300529NEOGMEDSKAN268A69601066MOVEEBOPOLYMEDDRW8.DE6-month return →1-month return →
Up and to the right = strong over both horizons. Draegerwerk AG & Co. KGaA is the large dot.

Fundamentals: revenue growth against valuation

0%+20%0×50×100×150×6951METNVCYTBONEX2276688029EKTA-B300529NEOG002901MEDSKAN69601066POLYMEDDRW8.DERevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Draegerwerk AG & Co. KGaA is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%6951VCYTBONEX2276688029EKTA-B300529002901SKAN268A69601066EBODRW8.DEGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Draegerwerk AG & Co. KGaA is the large dot.

Draegerwerk AG & Co. KGaA competitors and peer comparison

Head to head with its named competitors (DRW8.DE vs GEHC vs MSA vs GETI-B.ST)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Draegerwerk AG & Co. KGaA DRW8.DE$2.13B+25%+5%7%10.2×-10.2%
GE HealthCare GEHC$37.8B+30%+7%14%15.6×5.0%
MSA Safety MSA$6.84B+5%+8%22%18.3×9.4%
Getinge GETI-B.ST$7.45B+40%-4%14%21.1×5.0%

How Draegerwerk AG & Co. KGaA compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Draegerwerk AG & Co. KGaA against its 20 peers (data as of 18 Nov 2026)
MeasureDRW8.DEPeer medianRank in peer set
1-month return+28.1%-0.8%3rd highest of 21
6-month return+24.9%+1.1%4th highest of 20
Distance from 52-week high-6.9%-20.3%5th highest of 21
Revenue growth (TTM)+5.1%+7.9%8th lowest of 21
Operating margin7.4%15.2%7th lowest of 21
Forward P/E10.2×24.1×2nd cheapest of 19
Growth the price implies (Req g, 7 yrs)-10.2%10.7%2nd least demanding of 14
Growth delivered (Del g)+0.4%+10.4%2nd lowest of 14
Hurdle (Req g minus delivered)-10.7 pp-2.2 pp5th least demanding of 14
ROIC minus cost of capital+5.1 pp-0.6 pp9th highest of 21
EV / EBITDA4.7×17.1×2nd cheapest of 15
Net debt / EBITDA-0.1×-0.7×8th most indebted of 16

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Draegerwerk AG & Co. KGaA DRW8.DEGermany$2.13B+25%+5%7%10.2×-10.2%+0.4%
JEOL 6951.TJapan$2.12B-2%-15%12%15.5×22.2%+10.2%
Establishment Labs ESTAUnited States$2.11B+1%+38%-7%n/an/an/a
Metall Zug METN.SWSwitzerland$2.19B+20%0%-10%139.8×n/an/a
Veracyte VCYTUnited States$2.06B-43%+18%16%17.1×18.0%+34.5%
Bonesupport BONEX.STSweden$2.06B+21%+25%25%61.5×12.6%+45.4%
Shanghai Conant Optical 2276.HKHong Kong$2.25B-17%+8%29%22.1×-1.1%+14.1%
Micro-Tech (Nanjing) 688029.SSChina$2.33B0%+6%18%28.1×11.9%+19.2%
Elekta EKTA-B.STSweden$2.35B0%-7%6%15.3×10.7%+4.0%
Jafron Biomedical 300529.SZChina$2.35B+3%+1%37%24.3×6.1%+0.6%
Neogen NEOGUnited States$2.42B+25%0%0%32.6×n/an/a
Double Medical Technology 002901.SZChina$2.43B-2%+13%26%24.2×7.6%+10.4%
Medartis MED.SWSwitzerland$1.86B+47%+30%2%72.8×n/an/a
SKAN SKAN.SWSwitzerland$1.85B+40%+9%11%49.5×13.8%+11.7%
Molbio Diagnostics MOLBIO.NSIndia$1.85Bn/a+35%17%n/an/an/a
Rigaku 268A.TJapan$1.85B-54%+9%16%23.1×18.3%+14.5%
Fukuda Denshi 6960.TJapan$1.84B+4%0%19%15.4×-1.6%-1.0%
Shandong Weigao Group Medical Polymer 1066.HKHong Kong$1.82B-8%+7%14%8.2×-12.6%+2.1%
Medacta MOVE.SWSwitzerland$2.48B-28%+8%15%24.0×n/an/a
EBOS EBO.AXAustralia$2.50B+7%+3%3%15.7×4.7%+6.8%
Poly Medicure POLYMED.NSIndia$1.79B+14%+25%16%39.9×n/an/a

Questions

Who are Draegerwerk AG & Co. KGaA's main competitors?
Named competitors: GE HealthCare (GEHC), MSA Safety (MSA), Getinge (GETI-B.ST). The cockpit's measured peer set (industry) also includes JEOL (6951.T), Establishment Labs (ESTA), Metall Zug (METN.SW), Veracyte (VCYT), Bonesupport (BONEX.ST), Shanghai Conant Optical (2276.HK).
Is Draegerwerk AG & Co. KGaA expensive compared with its peers?
On forward p/e it trades at 10.2× against a peer median of 24.1×, 2nd cheapest of 19 in its peer set. For today's price to make sense, revenue must grow about -10% a year for seven years (Req g). Recent delivered growth is 0%, so the hurdle is -11 pp: the price already allows for a slowdown.
How has Draegerwerk AG & Co. KGaA stock performed?
Over six months to 18 Nov 2026 the shares returned +24.9% against +1.1% for the median peer; over one year +43.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.